Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: neuroscience – Page 355

Common drug restores youthful function to clean up aging brains

First described by Nedergaard and her colleagues in 2012, the glymphatic system is the brain’s unique waste removal process that uses cerebrospinal fluid (CSF) to wash away excess proteins generated by energy hungry neurons and other cells in the brain during normal activity.

A drug used to induce labor in pregnant women has been shown to reactivate tiny waste-clearing pumps in the brains of old mice. The finding could hold promise as a new way to fight Alzheimer’s and Parkinson’s diseases and overall cognitive decline.

When our brains are working properly, there is an excess of proteins that build up from the energy intensive processes that take place between our neurons. Those proteins need to be removed in order for the brain to continue to operate properly. When they aren’t, they can gunk up the works, leading to the beta amyloid and tau protein tangles that are a hallmark of Alzheimer’s disease or the build up of alpha-synuclein that accompanies Parkinson’s.

In 2012 Danish neuroscientist, Maiken Nedergaard first described the system that uses cerebrospinal fluid (CSF) to remove waste from the brain and termed it the glymphatic system. Now, Nedergaard and her colleagues have looked deeper into the glymphatic system, focusing on lymph vessels called lymphangions. These are a series of tiny pumps in the neck that are responsible for moving dirty CSF out of the brain and into the lymph system where it ultimately reaches the kidneys to be processed.

“Virtual Reality Is GENUINE Reality“ | David Chalmers Mindfest Lecture

Philosopher and cognitive scientist David Chalmers explores virtual reality and its implication for our understanding of existence. Chalmers examines the simulation hypothesis, challenging conventional views of reality and suggesting that virtual worlds might be as real and meaningful as the physical world. This is a thought-provoking lecture at MindFest, held at Florida Atlantic University, CENTER FOR THE FUTURE MIND, spearheaded by Susan Schneider.

TIMESTAMPS:
00:00 — Intro.
01:34 — Overview.
11:55 — David’s Central Thesis.
15:55 — Biosim vs. Pure Sim.
18:11 — Imperfect vs. Perfect Simulation.
26:38 — Are Simulations Illusions?
31:29 — It-From-Bit Hypothesis.
36:06 — What Is The Metaverse?
43:58 — Meaning In A Virtual World.
51:49 — Q\&A
01:06:43 — Outro.

NOTE: The perspectives expressed by guests don’t necessarily mirror my own. There’s a versicolored arrangement of people on TOE, each harboring distinct viewpoints, as part of my endeavor to understand the perspectives that exist.

THANK YOU: To Mike Duffey for your insight, help, and recommendations on this channel.

Support TOE:
- Patreon: / curtjaimungal (early access to ad-free audio episodes!)
- Crypto: https://tinyurl.com/cryptoTOE
- PayPal: https://tinyurl.com/paypalTOE
- TOE Merch: https://tinyurl.com/TOEmerch.

Follow TOE:

Continue reading ““Virtual Reality Is GENUINE Reality“ | David Chalmers Mindfest Lecture” | >

New insights into neural circuit imaging: A comparison of one-photon and two-photon techniques

In the quest to unravel the complexities of neural circuits, scientists are beginning to use genetically encoded voltage indicators (GEVIs) to visualize electrical activity in the brain. These indicators are crucial for understanding how neurons communicate and process information. However, the effectiveness of one-photon (1P) versus two-photon (2P) voltage imaging has remained a topic of debate. A recent study by researchers at Harvard University sheds light on the relative merits and limitations of these two imaging techniques, providing valuable insights for the scientific community.

Engineering Toxoplasma gondii secretion systems for intracellular delivery of multiple large therapeutic proteins to neurons

Bracha et al.

Toxoplasma gondii culture and maintenance.

Type I RH and type II Pru and ME49 strain T. gondii were grown in HFF in high-glucose Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 4 mM l-glutamine, 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin or 20 μg ml−1 gentamicin antibiotics (‘complete DMEM’) at 37 °C with 5% CO2. Cultures were monitored daily and T. gondii were passaged by transferring 1–3 drops (20–100 μl) of the supernatant of a lysed dish (containing extracellular parasites) into a fresh dish with confluent HFF cells. Type I RH and type II Pru strains were validated by PCR–restriction-fragment length polymorphism (primers described in Supplementary Table 1)81 or by passage into Cre Reporter cell lines to confirm Cre recombination as previously described16.

Scientists capture clearest glimpse of how brain cells embody thought

This explores how the human brain forms abstract concepts and adapts to changing environments, specifically looking at how neurons in certain brain regions contribute to complex thinking.

It takes brains to infer how any two things in the world relate to each other, whether it’s the way bad weather links to commuting delays or how environmental conditions lead to the evolution of species. A new study based on recordings in the brains of people has yielded a pathbreaking trove of data that researchers now have used to reveal, with more clarity than ever, the neural incarnations of inferential reasoning.

New findings reveal how serotonin shapes behavior in negative situations

In a recent study in Nature Communications, researchers increased synaptic serotonin through a selective serotonin-releasing agent (SSRA), fenfluramine, to investigate its impact on human behavior.

Neuroscience research concentrates on the function of central serotonin (5HT) in human behavior, specifically the impact of selective serotonin reuptake inhibitors (SSRIs). Serotonin is necessary for several actions, including eating, sexual function, and goal-directed cognition.

It is difficult to determine the causal relationship between increased synaptic 5-HT and behavior in humans via SSRIs due to SSRIs’ complicated effects on 5-HT and colocalized neurotransmitter systems. A low dose of fenfluramine, approved for the treatment of Dravet epilepsy in 2020, directly and swiftly elevates synaptic 5-HT without altering extracellular dopamine concentrations in mood control areas.

/* */